Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China
· Delayed Price · Currency is CNY 21.76
+0.25 (1.16%)
Mar 10, 2026, 2:14 PM CST
SHA:600671 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 33.15 | 15.25 | -38.28 | -67.52 | -29.8 | -40.52 | Upgrade
|
| Depreciation & Amortization | 18.58 | 18.58 | 15.01 | 18.34 | 12.3 | 8.66 | Upgrade
|
| Other Amortization | 3.47 | 3.47 | 1.21 | 2.42 | 2.29 | 2.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | 0 | -0.33 | 0.09 | -0.04 | -1.72 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.83 | 0.83 | 6.01 | 17.76 | 2.92 | 22.47 | Upgrade
|
| Loss (Gain) From Sale of Investments | -0.03 | -0.03 | 0.53 | -0.96 | - | -0.07 | Upgrade
|
| Provision & Write-off of Bad Debts | 2.29 | 2.29 | -2.99 | 4.99 | 4.05 | 3.72 | Upgrade
|
| Other Operating Activities | 3.47 | 13.25 | 11.5 | 14.05 | 9.81 | 16.21 | Upgrade
|
| Change in Accounts Receivable | -64.08 | -64.08 | -6.41 | 43.19 | -27.41 | -35.88 | Upgrade
|
| Change in Inventory | -9.38 | -9.38 | 4.87 | -1.15 | 11.79 | -10.11 | Upgrade
|
| Change in Accounts Payable | -16.42 | -16.42 | -11.57 | -49.65 | -13.93 | 31.32 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | -2.13 | 2.32 | -4.7 | Upgrade
|
| Operating Cash Flow | -28.55 | -36.67 | -20.43 | -19.37 | -26.42 | -8.4 | Upgrade
|
| Capital Expenditures | -34.95 | -20.55 | -8.96 | -3.52 | -4.71 | -11.84 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.02 | 0 | 0.17 | 0 | 0.34 | 1.8 | Upgrade
|
| Cash Acquisitions | 0.36 | -6.31 | - | -2.2 | 0.22 | - | Upgrade
|
| Divestitures | - | - | -0.04 | -0.08 | - | 2.56 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -1.3 | Upgrade
|
| Other Investing Activities | -0.35 | - | - | - | - | -2.48 | Upgrade
|
| Investing Cash Flow | -34.93 | -26.86 | -8.83 | -5.8 | -4.16 | -11.26 | Upgrade
|
| Short-Term Debt Issued | - | 149.71 | 102.45 | 110.45 | 181.2 | 149.8 | Upgrade
|
| Long-Term Debt Issued | - | 81.47 | 59.45 | 55.65 | - | - | Upgrade
|
| Total Debt Issued | 239.48 | 231.18 | 161.9 | 166.1 | 181.2 | 149.8 | Upgrade
|
| Short-Term Debt Repaid | - | -205.75 | -162.04 | -112.55 | -145.83 | -135.18 | Upgrade
|
| Long-Term Debt Repaid | - | -8.33 | -4.78 | -60.27 | -44.09 | - | Upgrade
|
| Total Debt Repaid | -177.92 | -214.09 | -166.82 | -172.82 | -189.92 | -135.18 | Upgrade
|
| Net Debt Issued (Repaid) | 61.56 | 17.09 | -4.92 | -6.72 | -8.72 | 14.62 | Upgrade
|
| Issuance of Common Stock | 7.43 | 7.43 | 90 | 0.27 | - | - | Upgrade
|
| Common Dividends Paid | -9.56 | -8.58 | -6.67 | -4.78 | -6.71 | -7.01 | Upgrade
|
| Other Financing Activities | -4.37 | -2.9 | 6.41 | 67.29 | 49.94 | -0.11 | Upgrade
|
| Financing Cash Flow | 55.07 | 13.04 | 84.83 | 56.06 | 34.52 | 7.51 | Upgrade
|
| Net Cash Flow | -8.4 | -50.5 | 55.57 | 30.89 | 3.94 | -12.14 | Upgrade
|
| Free Cash Flow | -63.5 | -57.23 | -29.38 | -22.89 | -31.13 | -20.23 | Upgrade
|
| Free Cash Flow Margin | -25.24% | -26.34% | -24.13% | -21.02% | -21.17% | -9.79% | Upgrade
|
| Free Cash Flow Per Share | -0.52 | -0.47 | -0.24 | -0.19 | -0.25 | -0.17 | Upgrade
|
| Cash Income Tax Paid | 29.14 | 13.72 | 6.13 | 2.99 | 8.25 | 7.62 | Upgrade
|
| Levered Free Cash Flow | -108.38 | -25.67 | -12.72 | 37.87 | 42.11 | 5.93 | Upgrade
|
| Unlevered Free Cash Flow | -105.06 | -22.19 | -8.23 | 42.5 | 46.71 | 10.26 | Upgrade
|
| Change in Working Capital | -90.32 | -90.32 | -13.1 | -8.55 | -27.96 | -19.23 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.